CPATH Ethical Guidelines for Research Involving Transgender People & Communities
CPATH Statements, Letters, and Positions
As CPATH develops as an organization, so does its commitment to clear statements with regards to standards, policy, and positions. Developed by committees and approved by the board, national consensus statements, letters, and positions are available to the health care providers, federal and provincial institutions, and members of the general public.
2025
- Statement from the Canadian Professional Association for Transgender Health (CPATH) on the Alberta Government’s Anti-Trans Legislation and the Use of the Notwithstanding Clause (Oct)
- Déclaration de l’Association professionnelle canadienne pour la santé transgenre (CPATH) sur la législation anti-transgenres du gouvernement de l’Alberta et le recours à la clause dérogatoire (Oct)
2020
- Statement Regarding Medical Affirming Treatment including Puberty Blockers for Transgender Adolescents – WPATH, EPATH, USPATH, AsiaPATH, CPATH, AusPATH, PATHA Response to Bell v. Tavistock Judgment
- CPATH Position Statement on “rapid-onset gender dysphoria”
2015
- Bill 77 Submission Affirming Sexual Orientation and Gender Identity Act 2015 (Sep)
- Literature Review to Support Health Service Planning for Transgender People (Sep)
- New Brunswick Medicare Coverage for Gender Related Medical Care, Explicit Human Rights Inclusion and Sex Designation Change on Identification Documents (Jun)
2014
2013
- CPATH letter to NS Minister of Health and Wellness (Jun)
- Lettre de Soutien au Québec Projet de loi 35 (May)
2012
- CPATH Letter of Resolution to Minister of Justice Re Safe Regulation of Sex Work (Apr)
- CPATH Letter to Ministers of Health (Feb)
- Lettre aux Ministres provinciaux de la santé (Fev)
2011
2010
- CPATH Bill C-389 to Committee (Jun)
- CPATH Human Rights Bill C-389 (May)
- WPATH De-psychopathologisation Statement (May)
- EGALE-CPATH Bill C-389 (Apr)
- CPATH Position Statement PDF-DSM5 and ICD11 (Mar)
2009